Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

O
O’Croinin, Conor

University of Alberta
(M1030-02-10) Exploring the Influence of Dietary Components and Excipients on Intestinal Lymphatic Drug Absorption: Findings from an Advanced In Vitro Approach
Conor O’Croinin
Favorite
O’Reilly Beringhs, Andre

US Food and Drug Administration
(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles
Andre O’Reilly Beringhs
Favorite
Oakes, Robert

University of Maryland
(M1230-10-54) 3D-Printed Microneedles Delivering Regulatory Immune Cues to Antigen-Presenting Cells in the Skin Promote Immune Tolerance
Robert Oakes
Favorite
Oberoi, Hardeep

AbbVie Inc.
(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530
Hardeep Oberoi
Favorite
OBrien, Shona

Ashland Specialty Ingredients
(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies
Shona OBrien
Favorite
O'Connor, Thomas

US Food and Drug Administration
(T1430-11-61) Predictive Residence Time Distribution Models for Continuous Powder Blending
Thomas O'Connor
Favorite
O'Dwyer, Patrick

University College Cork
(T1130-06-33) Investigating the Modelability of Human Oral Fraction Absorbed using Regulatory Data
Patrick O'Dwyer
Favorite
O'Farrell, Connor

InnoGI Technologies
(T1230-10-57) Biorelevant Dissolution Testing in Tiny-TIMsg to Improve Predictivity of Food Effect on Oral Delivery of BCS Class II Compound
Connor O'Farrell
Favorite
(W1130-07-40) Integrating Bioaccessibility Data from the Tiny-TIMsg into a Physiologically Based Biopharmaceutics Model (PBBM) of a BCS Class IV Compound to Predict Pharmacokinetic (PK) Performance
Connor O'Farrell
Favorite
Ognibene, Ted

Lawrence Livermore National Laboratory
(M0930-06-31) Parallel Accelerator and Molecular Mass Spectrometry for Tracing ¹⁴C-Labeled Metabolites
Ted Ognibene
Favorite
(T1130-11-63) Optical Radiocarbon (¹⁴C) Tracing for Biological and Pharmaceutical Applications
Ted Ognibene
Favorite
Ogueri, Kenneth

Pfizer Inc.
(W1130-09-52) Insights in Designing Osmotic Modified Release Delivery Platform for Solid Dispersions: Challenges and Conception
Kenneth Ogueri
Favorite
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Kenneth Ogueri
Favorite
O'Hara, Karen

Eisai Ltd.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Karen O'Hara
Favorite
Ohhashi, Ryo

Meiji Pharmaceutical University
(W1230-11-61) In Situ Monitoring of Dissolution and Crystallization Processes for Active Pharmaceutical Ingredients Using Low Frequency Raman Spectroscopy
Ryo Ohhashi
Favorite
Oh, Kyung Taek

Chung-Ang University
(M1130-01-05) Novel Cell-Penetrating Peptide-Based Therapy for Treating Atopic Dermatitis
Kyung Taek Oh
Favorite
Okada, Yuka

Tomita Pharmaceutical Co., Ltd.
(M1030-10-57) A Solution that Improves the Poor Soluble API Dissolution by Using Porous Calcium Silicate FLORITE^®
Yuka Okada
Favorite
Okado, Toshiaki

Nippon Soda Co., Ltd.
(M1230-10-56) Sodium Stearyl Fumarate vs. Magnesium Stearate: Understanding the Mechanism of Over-Lubrication
Toshiaki Okado
Favorite
Okawara, Masaki

Sunsho Pharmaceutical Co., Ltd.
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Masaki Okawara
Favorite
Okezue, Mercy

University of Michigan
(W0930-11-64) Developing an Assessment Framework, Items, and Expert Reviews for an Educational Instrument for the Proper Use of the USP/NF Pharmacopeia
Mercy Okezue
Favorite
Okuda, Hiroki

Gifu Pharmaceutical University
(T1330-10-56) Development of Inhaled Dry Powder Using Electrospinning Method
Hiroki Okuda
Favorite
Olajubutu, Oluwabukunmi

Howard University
(M1530-01-03) Targeted Cell-Penetrating Peptide-Drug Conjugates for the Treatment of Pancreatic Cancer
Oluwabukunmi Olajubutu
Favorite
Oldenhof, John

BioPharma Services Inc.
(M0930-02-12) Sex, Racial, and Ethnic Representation in COVID-19 Vaccine Clinical Trials Conducted in US - A Systematic Review Compared to 2020 US Census Data
John Oldenhof
Favorite
(M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
John Oldenhof
Favorite
Oliveira, Lucas

Federal University of Rio Grande do Norte
(M1430-07-38) Nanotechnological Approach to Cannabidiol Delivery: Production and Characterization of Microemulsion for Oral Administration
Lucas Oliveira
Favorite
Oliveira, Wogenes

Federal University of Rio Grande do Norte
(M1430-07-38) Nanotechnological Approach to Cannabidiol Delivery: Production and Characterization of Microemulsion for Oral Administration
Wogenes Oliveira
Favorite
Oliver, Lee

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Lee Oliver
Favorite
Omar, Spozhmai

Duquesne University
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Spozhmai Omar
Favorite
Omidian, Hossein

Nova Southeastern University
(M0930-07-38) Evaluating Mucoadhesion of Polymer Films Using Wax Substrates with Mucin Coating
Hossein Omidian
Favorite
(M1530-04-20) Polymer Effects on Kolliphor P407's Mucoadhesion
Hossein Omidian
Favorite
(T1030-04-20) Impact of Freeze-Thaw Cycles on Kolliphor P407's Thermogelling and Mucoadhesion
Hossein Omidian
Favorite
(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time
Hossein Omidian
Favorite
O'Neill, Sean

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Sean O'Neill
Favorite
Ong, Jun Jie

University College London
(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers
Jun Jie Ong
Favorite
Ong, Whitney

Merck & Co., Inc.
(T1530-02-10) Validating Gut-On-A-Chip-Model: Comparison of Caco-2 Transwell and Gut-On-A-Chip Models for Oral Drug Delivery
Whitney Ong
Favorite
Onoue, Satomi

University of Shizuoka
(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach
Satomi Onoue
Favorite
(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix
Satomi Onoue
Favorite
Ooashi, Tatsuya

Nissor Pharmaceuticals Ltd.
(M1230-10-56) Sodium Stearyl Fumarate vs. Magnesium Stearate: Understanding the Mechanism of Over-Lubrication
Tatsuya Ooashi
Favorite
Oottamasathein, Siam

Harvard Medical School
(W0930-04-19) Quantitative Phase Imaging for Evaluation of the Radioprotective Effects of Synthetic Glycosaminoglycans on Immune Cells
Siam Oottamasathein
Favorite
Opere, Catherine

Creighton University
(T1530-04-22) A Novel Hybrid Gasotransmitter for an Unmet Need of Glaucoma Therapy: A Proof-of-Concept Study
Catherine Opere
Favorite
Oppong, Edwina

Texas Southern University
(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams
Edwina Oppong
Favorite
Orozco-Castellanos, Luis Manuel

Universidad de Guanajuato
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Luis Manuel Orozco-Castellanos
Favorite
Orr, Natalie

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Natalie Orr
Favorite
Orsi, Daniela

University of Brasilia
(M1330-06-35) In Vitro Irritability, Toxicity, and Anti-Inflammatory Activity of Rosehip Oil Emulsion
Daniela Orsi
Favorite
Orth, Dave

Thermo Fisher Scientific
(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation
Dave Orth
Favorite
Ortiz, Jairo

Johns Hopkins University
(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue
Jairo Ortiz
Favorite
O'Shea, Joseph

University College Cork
(W1030-04-21) Computational Pharmaceutics Approaches to Guide Lipid Based Formulation Development: How Data Mining Can Improve the Process
Joseph O'Shea
Favorite
Otavalo, Gabriela

Universidad de Chile
(M1330-09-51) Synthesis and Characterization of Nanostructured Lipid Carriers (NLC) with Bile Salts: Sodium Deoxycholate (SDC), Sodium Deoxyglycholate (SDGC) and Sodium Deoxytaurocholate (SDTC)
Gabriela Otavalo
Favorite
Otieno, Monicah

Bill & Melinda Gates Medical Research Institute
(M1130-02-08) Kinetics of Sutezolid Metabolism to Its Active Metabolite and Identification of the Relevant Drug Metabolizing Enzymes
Monicah Otieno
Favorite
Ou, Mingxi

Chinese University of Hong Kong, The
(M1130-04-19) Evaluation of Piperine Nanoparticles for FXTAS Treatment via CGG Repeat Drosophila Model
Mingxi Ou
Favorite
Oupicky, David

University of Nebraska Medical Center
(M1230-01-06) Development of Inhalable CXCR4 Targeted Polymeric Nanoemulsions for Delivery of RNAi Therapeutics to Enhance Anti-PD-L1 Immunotherapy in Lung Tumors
David Oupicky
Favorite
(M1330-01-03) Developing Lipid Nanoparticles (LNPs) for mRNA Delivery in Pancreatic Cancer (PC)
David Oupicky
Favorite
(M1430-07-39) Targeting Resistant Pathogens: The Promise of Vancomycin-Silver Nanoparticle Hybrids Against Vancomycin-Intermediate Staphylococcus Aureus (VISA)
David Oupicky
Favorite
(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease
David Oupicky
Favorite
(T1430-01-02) Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy
David Oupicky
Favorite
Ovacik, Meric

Genentech, Inc.
(M1530-02-12) Characterizing Interactions of RO7297089, an Anti-B-Cell Maturation Antigen (BCMA)/CD16A Bispecific Tetravalent Antibody with Shed Soluble CD16A Antigen in Plasma In Vitro
Meric Ovacik
Favorite
Overfield, Jeffrey

Aprecia Pharmaceuticals Company
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Jeffrey Overfield
Favorite
Owens, Donald

TFF Pharmaceuticals, Inc.
(T1030-10-57) Dry Powders of a Rabies G Protein mRNA Vaccine Candidate Prepared by Thin-Film Freeze-Drying
Donald Owens
Favorite
Oza, Kamlesh

Evonik Corporation
(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles
Kamlesh Oza
Favorite
(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b
Kamlesh Oza
Favorite
Ozoude, Chukwuebuka

North Dakota State University
(T1330-01-03) Development of Hypoxia-Responsive Polymersomes for Drug Delivery to Pancreatic Ductal Adenocarcinoma (PDAC) Cells
Chukwuebuka Ozoude
Favorite